WW
Highly rated in
1
conditions

Dr. Wolfgang A. Weber

Memorial Sloan Kettering Cancer Center
New York, NY
Highly rated in
1
conditions
Specialties:Nuclear Medicine
Experience:30 Years
Clinical Trials:Currently Recruiting for 3 Trials
Accepts:New Patients
Highly rated in
1
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Wolfgang A. Weber's experience treating your condition:
About Dr. Wolfgang A. Weber

Wolfgang Weber is a Nuclear Medicine expert in New York, New York. Weber has been practicing medicine for over 30 years and is highly rated in 1 condition, according to our data. His top areas of expertise are Gastroesophageal Junction Cancer, Ptosis, Neurofibromatosis, Prostatectomy, and Gamma Knife Radiosurgery. He is licensed to treat patients in New York. Weber is currently accepting new patients.

His clinical research consists of co-authoring 325 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Wolfgang A. Weber it is best to call his office and ask if your insurance is accepted.

Dr. Wolfgang A. Weber accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
1275 York Ave, New York, NY 10065
Background & Education
Graduate Institution
Other, 1993
Specialties
Nuclear Medicine
Licenses
Nuclear Imaging & Therapy in NY
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
Enrollment Status: Recruiting
Publish Date: November 25, 2022
Intervention Type: Drug
Study Drug: Fluorescent cRGDY-PEG-Cy5.5-C Dots
Study Phase: Phase 1/Phase 2
A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas
Enrollment Status: Recruiting
Publish Date: June 06, 2022
Intervention Type: Drug
Study Drug: Olaparib
Study Phase: Phase 1/Phase 2
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Enrollment Status: Recruiting
Publish Date: May 18, 2022
Intervention Type: Drug
Study Drug: Cladribine s.c. Injection, HCL treatment
Study Phase: Phase 2/Phase 3
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Enrollment Status: Active, not recruiting
Publish Date: December 08, 2022
Intervention Type: Radiation, Device
Study Phase: Not Applicable
Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma; a Prospective, Single-arm, Open Label, Multicenter Phase II Study: HOMIE-166.
Enrollment Status: Not yet recruiting
Publish Date: November 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
PET Imaging of Thyroid Tissue Expressing Sodium-iodine Symporter Using the New Tracer 18F-tetrafluoroborate (18F-TFB)
Enrollment Status: Active, not recruiting
Publish Date: June 03, 2022
Intervention Type: Other, Procedure
Study Phase: Not Applicable
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Radiation, Device
Study Phase: Not Applicable
A Phase II Study of 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Radiation, Device
Study Phase: Phase 2
A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug
Study Phase: Phase 1
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial
Enrollment Status: Unknown status
Publish Date: December 16, 2010
Intervention Type: Radiation
Study Phase: Phase 2
View 7 Less Clinical Trials -
325 Total Publications
A theranostic approach for CAR-T cell therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 09, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
ST
Dr. Sabino R. Torre
Nuclear Medicine | Cardiology | Interventional Cardiology
Highly rated in
17
conditions
Nuclear Medicine
Cardiology
Interventional Cardiology

RWJBarnabas Health

West Orange Office

375 Mount Pleasant Ave, 
West Orange, NJ 
 16.0 mi

Sabino Torre is a Nuclear Medicine specialist and a Cardiologist in West Orange, New Jersey. Torre has been practicing medicine for over 38 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Metabolic Syndrome, Stable Angina, Aortic Valve Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in New Jersey. Torre is currently accepting new patients.

HS
Dr. Heiko M. Schoder
Nuclear Medicine
Highly rated in
3
conditions
Nuclear Medicine

Memorial Nuclear Medicine Group

1275 York Ave, 
New York, NY 

Heiko Schoder is a Nuclear Medicine expert in New York, New York. Schoder has been practicing medicine for over 25 years and is highly rated in 3 conditions, according to our data. His top areas of expertise are Classical Hodgkin Lymphoma, T-Cell Lymphoma, Lung Nodules, Orchiectomy, and Tissue Biopsy. He is licensed to treat patients in New York. Schoder is currently accepting new patients.

HJ
Dr. Hitender Jain
Nuclear Medicine | Cardiology
Highly rated in
18
conditions
Nuclear Medicine
Cardiology

Catholic Health

South Bay Cardiovascular - West Islip

540 Union Blvd, 
West Islip, NY 
 34.8 mi

Hitender Jain is a Nuclear Medicine specialist and a Cardiologist in West Islip, New York. Jain has been practicing medicine for over 29 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and Fainting. He is licensed to treat patients in New York.